Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues

CompletedOBSERVATIONAL
Enrollment

470

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 21, 2018

Study Completion Date

July 21, 2018

Conditions
Prostate Cancer
Trial Locations (32)

13005

Hospital de Ciudad Real, Ciudad Real

15006

Hospital Universitario A Coruña, A Coruña

15706

Complejo Clínico Universitario de Santiago, Santiago de Compostela

20014

Hospital de Donosti, San Sebastián

24008

Hospital de León, León

28006

Hospital de la Princesa, Madrid

28046

Hospital Univ. La Paz, Madrid

28500

Hospital Sureste, Arganda

Hospital del Sureste, Arganda de Rey, Madrid

28702

Hospital Infanta Sofía, San Sebastián de los Reyes

28905

Hospital Getafe, Getafe

36200

H. Do Meixoeiro, Vigo

37007

Hospital de Salamanca, Salamanca

38010

H. Univ. Nuestra Señora de la Candelaria, Santa Cruz de Tenerife

47003

Hospital Clínico de Valladolid, Valladolid

48013

Hospital de Basurto, Bilbao

430005

Hospital Joan XXIII, Tarragona

3000-075

Hospital Universitário de Coimbra, Coimbra

1150-199

Hospital de São José, Lisbon

1649-035

Hospital de Santa Maria, Lisbon

4454-509

Hospital Pedro Hispano, Matosinhos Municipality

4099-001

Hospital Geral de Santo António, Porto

08923

Hospital Esperit Sant, Santa Coloma de Gramenet

08916

Hospital Germans Trias I Pujol, Badalona

08003

H. del Mar, Barcelona

08035

H. Valle Hebrón, Barcelona

08907

H. Bellvitge, L'Hospitalet de Llobregat

08243

Hospital Althaia, Manresa

08208

H. Parc Tauli, Sabadell

08500

Hospital Universitari de Vic, Vic

01004

Hospital Santiago Apóstol, Vitoria-Gasteiz

01009

Hospital de Txagorritxu, Vitoria-Gasteiz

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY